Antipsychotics & diabetes 1 October 2013 People who take atypical antipsychotics have an increased risk of developing diabetes. Atypical antipsychotics are usually used to treat schizophrenia, bipolar disorder, dementia, anxiety disorder, Austism Spectrum Disorder and obsessive-compulsive disorder. If you already have diabetes, you have an increased risk of developing hyperglycaemia (high blood glucose levels outside target range) when starting antipsychotics. While it is not clear why atypical antipsychotics affect blood glucose levels, it is believed that these medications stop the brain from sensing when the body has had enough to eat, leading to weight gain and insulin resistance. If you are taking atypical antipsychotics and experiencing blood glucose levels higher than the recommended target, you should NOT stop taking your medication. Instead, it is important that you discuss this with your GP, endocrinologist, physician or psychiatrist. For more information contact: Your state based diabetes organisation infoline on 1800 637 700 Beyond Blue
Blog 18 November 2026 Make a splash: Water exercise for diabetes As the weather warms up, it can be less enticing to go for that walk or bike ride, so why... Continue Reading
Media releases 18 November 2026 Foundayo approval a welcome addition to GLP-1 treatment options Diabetes Australia has welcomed the TGA approval of Foundayo (orforglipron), a new oral GLP-1 receptor agonist for the management of type 2 diabetes and chronic weight management in eligible adults. Continue Reading
Blog 18 November 2026 Five days of easier meal decisions Discover five days of realistic meal ideas designed to help you enjoy a variety of foods, save time in the kitchen, and make nutritious choices with less stress and planning. Continue Reading